Greenbrook TMS NeuroHealth Centers: Company Research Report

Company Overview

• Name: Greenbrook TMS NeuroHealth Centers

• Mission: No explicit mission statement is provided in the data available.

• Founded and By Whom: No information is available.

• Key People:

• Dr. Steven Harvey, Regional Medical Director, Missouri

• Kathy Sharp PMHNP-BC, Illinois

• Dr. Heather Kurera, California

• Dr. Hanita Chhabra, Regional Medical Director, Maryland

• Headquarters: No information is available.

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known For: Greenbrook TMS is known for providing Transcranial Magnetic Stimulation (TMS) therapy and Spravato® esketamine nasal spray treatment for Major Depressive Disorder and other mental health disorders in the United States.

Products

Transcranial Magnetic Stimulation (TMS) Therapy

• Description: TMS therapy is a non-invasive, FDA-cleared treatment for Major Depressive Disorder and Obsessive Compulsive Disorder.

• Key Features:

• Directly targets brain regions associated with mood regulation via electromagnetic stimulation.

• It is suitable for patients 15 years and older who have not responded satisfactorily to antidepressant medications.

• Evidence suggests that 83% of patients see at least a 50% reduction in depressive symptoms, with 62% achieving remission.

Spravato® (Esketamine Nasal Spray)

• Description: Spravato® is an FDA-approved, ketamine-based treatment used primarily for treatment-resistant depression.

• Key Features:

• Targets the glutamate system to promote new neural pathways in the brain.

• Approved for adults experiencing depressive symptoms despite traditional antidepressant medications.

• Administered at select Greenbrook NeuroHealth Center locations.

Recent Developments

• New Products Launched: Greenbrook now offers the only FDA-approved ketamine-based treatment for depression.

• New Features: No specific new features have been identified in existing products.

• Partnerships: No new partnerships are mentioned.

• Other Developments:

• Greenbrook has expanded to over 100 locations across the United States, facilitating greater access to its treatments.

• The company supports an accessible internet for patient interaction and resource provision.

Additional Offerings and Resources

• Insurance and Financing: Major insurance providers like Aetna, Anthem, Blue Cross Blue Shield, Humana, and United Healthcare cover TMS therapy. Medicare and Medicaid are accepted at select locations. The company offers assistance with the coverage and reimbursement process.

• CEU/CME Opportunities: Greenbrook provides no-cost continuing education opportunities for healthcare professionals focusing on depression and OCD.

• Patient Accessibility: The company ensures treatment accessibility through numerous locations and comprehensive care teams.

• Regional Clinical Liaison: Available for more personalized communication and support with healthcare professionals and patients.

Contact Information

• Phone: 855-494-4867

• Email: info@greenbrooktms.com

All Rights Reserved | Greenbrook TMS NeuroHealth Centers © 2024.
Terms of Use and Privacy powered by Innovasium.